SCHEMBL7310227

SCHEMBL7310227

O=C1OCC2CCc3ccccc3N12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.71
SRD5A1 P18405 1/20 0.47
OPRM1 P35372 4/20 0.44
OPRK1 P41145 3/20 0.44
OPRL1 P41146 3/20 0.44
HTR6 P50406 3/20 0.43
HTR2C P28335 3/20 0.41
HTR2B P41595 3/20 0.41
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
OXTR P30559 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554098 0.83 NOTUM (1.00) NOTUMOPRM1OPRK1OPRL1HTR6
SCHEMBL17382966 0.83 NOTUM (1.00) NOTUMOPRM1OPRK1OPRL1HTR6
SCHEMBL21839107 0.83 NOTUM (1.00) NOTUMOPRM1OPRK1OPRL1HTR6
SCHEMBL29896718 0.83 NOTUM (1.00) NOTUMOPRM1OPRK1OPRL1HTR6
SCHEMBL16589999 0.79 SRD5A1 (0.51) NOTUMSRD5A1
SCHEMBL7340995 0.79 NOTUM (0.49) NOTUMSRD5A1OPRM1OPRK1HTR2B
SCHEMBL16587000 0.79 NOTUM (0.49) NOTUMSRD5A1OPRM1OPRK1OPRL1
SCHEMBL7378144 0.79 NOTUM (0.49) NOTUMSRD5A1OPRM1OPRK1HTR2B
SCHEMBL7372067 0.79 NOTUM (0.49) NOTUMSRD5A1OPRM1OPRK1HTR2B
SCHEMBL31091227 0.77 NOTUM (0.56) NOTUMSRD5A1OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699680-B1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SANOFI SYNTHELABO (FR) 2000-03-08 EP claimed
US-5641785-A ANTIDEPRESSANTS, NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1997-06-24 US claimed
EP-0699680-A1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1996-03-06 EP claimed
WO-2015040424-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AND THEIR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS VERNALIS (R&D) LIMITED (GB) 2015-03-26 WO disclosed
EP-1210080-A2 USE OF MONOAMINE OXIDASE INHIBITORS FOR THE MANUFACTURE OF DRUGS INTENDED FOR THE TREATMENT OF OBESITY Sanofi-Aventis (FR) 2002-06-05 EP disclosed
EP-1078632-A1 Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity SANOFI-SYNTHELABO (FR) 2001-02-28 EP disclosed
WO-2001012176-A2 USE OF MONOAMINE OXIDASE INHIBITORS FOR THE MANUFACTURE OF DRUGS INTENDED FOR THE TREATMENT OF OBESITY SANOFI-SYNTHELABO (FR) 2001-02-22 WO disclosed
CN-1055472-C Oxazoloquinolinone derivatives, their preparation and their therapeutic use SYNTHELABO (FR) 2000-08-16 CN disclosed
EP-0699680-B1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SANOFI SYNTHELABO (FR) 2000-03-08 EP disclosed
US-5641785-A ANTIDEPRESSANTS, NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1997-06-24 US disclosed
US-5641785-A ANTIDEPRESSANTS, NERVOUS SYSTEM DISORDERS SYNTHELABO (FR) 1997-06-24 US disclosed
CN-1128763-A Oxazoloquinolinone derivatives, their preparation and their therapeutic use SYNTHELABO (FR) 1996-08-14 CN disclosed
EP-0699680-A1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1996-03-06 EP disclosed
EP-0699680-A1 Oxazoloquinolinone derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1996-03-06 EP disclosed